Tambocor
Indicated for cardiac arrhythmias, formulated to target sodium channels and alleviate electrical instability to support a normal heart rhythm.
Strengths: 50 · 100mg
Where to Check Availability
Medicine details
- Therapeutic class
Antiarrhythmic
- Pharmacological class
Class Ic Antiarrhythmic
- Contraindications
heart failure; history of myocardial infarction; second or third degree AV block
- Precautions and warnings
regular ECG monitoring required; avoid in patients with structural heart disease
- Minor side effects
dizziness; visual disturbances
- Moderate side effects
arrhythmia pro-arrhythmic effect; shortness of breath; fatigue
- Serious side effects
ventricular tachycardia — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
3M
- Onset Time
1–3 hours
- Duration
12 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
beta blockers; digoxin; amiodarone
- Age restrictions
Dose adjusted based on weight in children.
Patient summary
Indicated for cardiac arrhythmias, formulated to target sodium channels and alleviate electrical instability to support a normal heart rhythm.
Mechanism of action
Flecainide is a Class Ic antiarrhythmic agent. It slows conduction in the cardiac tissues by blocking sodium channels, which helps reduce electrical excitability and restore regular rhythm in atrial and ventricular conduction systems.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Passes into milk, use with caution.
Tambocor
Indicated for cardiac arrhythmias, formulated to target sodium channels and alleviate electrical instability to support a normal heart rhythm.
Editorial Notes
- Active ingredient(s): Flecainide
- Listed indication(s): Atrial Fibrillation, Atrial Flutter, Ventricular Arrhythmias
Usually available as
- 90 tablets - 50 mg1536-50-mg-18159
- 60 tablets - 100 mg1536-100-mg-18165